Nima Gharavi, MD, PhD is a leading dermatologist and key opinion leader in dermatologic surgery and Mohs micrographic surgery. He is the Chief of the Department of Dermatology, Director of Dermatologic surgery & Mohs micrographic surgery, and Director of the Micrographic Surgery & Dermatologic Surgery Fellowship at Cedars-Sinai Medical Center (CSMC). He is also an Associate Clinical Professor in the Departments of Medicine and Pathology & Laboratory Medicine, and co-director of the Cutaneous Malignancies Tumor Board at CSMC. Dr. Gharavi also serves as Editor-in-Chief for Journal of Cosmetic and Laser Therapy. A diplomate of the American Board of Dermatology and a fellow of both the American College of Mohs Surgery (ACMS) and the American Society for Dermatologic Surgery (ASDS), Dr. Gharavi has performed over 30,000 skin cancer and reconstructive procedures.
Dr. Gharavi graduated summa cum laude at UCLA, majoring in Cell and Molecular Biology with a specialization in Business and Administration, and received both his M.D. and Ph.D. degrees at UCLA. He then completed his internship at Cedars-Sinai and residency in Dermatology at UCLA. Following residency, Dr. Gharavi completed a rigorous fellowship at UCLA in Procedural Dermatology, which featured a full integration of Mohs micrographic surgery and reconstructive plastic surgery with laser and cosmetic surgery. Through this unique integration, along with his PhD background in the science of skin cancer and aging, Dr. Gharavi is a well-rounded and innovative surgeon.
Dr. Gharavi is the recipient of numerous academic awards, including the Lasky award for medical research, the Irvine Page young investigator award, and the ACMS Theodore Tromovitch award for his research on squamous cell carcinoma. He has been the recipient of grants from the American Heart Association, the National Institutes of Health, and the National Psoriasis Foundation. He has been voted as Top Doctor in Dermatology for 10 years straight by LA Magazine and Castle Connolly. His research interests include the molecular pathogenesis of high-risk skin cancers, particularly in immunosuppressed solid-organ transplant recipients, as well as wound healing, inflammation, and the aging process. He is a consultant and has served on the advisory board for several novel cancer and laser therapeutics. To date, Dr. Gharavi has published over 80 peer-reviewed manuscripts, abstracts and textbook chapters, and continues to lecture and teach at national and international conferences.
